statistiche ricercatore

CAMPIOTTI, LEONARDO

Distribuzione geografica

Continente	#
NA - Nord America	6.698
EU - Europa	3.564
AS - Asia	2.249
SA - Sud America	344
AF - Africa	46
Continente sconosciuto - Info sul continente non disponibili	5
OC - Oceania	4
Totale	12.910

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	6.610
IT - Italia	1.835
SG - Singapore	826
CN - Cina	476
UA - Ucraina	403
VN - Vietnam	374
SE - Svezia	297
BR - Brasile	283
DE - Germania	267
HK - Hong Kong	258
FR - Francia	182
IE - Irlanda	142
TR - Turchia	141
GB - Regno Unito	122
RU - Federazione Russa	88
FI - Finlandia	69
IN - India	55
MX - Messico	50
NL - Olanda	43
CA - Canada	32
AR - Argentina	23
PL - Polonia	23
BD - Bangladesh	22
JP - Giappone	21
AT - Austria	19
BE - Belgio	17
ES - Italia	17
ZA - Sudafrica	16
EC - Ecuador	12
IQ - Iraq	12
NG - Nigeria	10
SA - Arabia Saudita	9
LT - Lituania	7
PE - Perù	7
PK - Pakistan	7
ID - Indonesia	6
JO - Giordania	6
MA - Marocco	6
CL - Cile	5
CO - Colombia	5
MD - Moldavia	5
PT - Portogallo	5
UZ - Uzbekistan	5
VE - Venezuela	5
EU - Europa	4
KE - Kenya	4
PH - Filippine	4
AE - Emirati Arabi Uniti	3
AU - Australia	3
BO - Bolivia	3
CH - Svizzera	3
CR - Costa Rica	3
DZ - Algeria	3
KZ - Kazakistan	3
MK - Macedonia	3
QA - Qatar	3
AM - Armenia	2
AZ - Azerbaigian	2
BG - Bulgaria	2
CZ - Repubblica Ceca	2
EG - Egitto	2
ET - Etiopia	2
GR - Grecia	2
HU - Ungheria	2
IL - Israele	2
IR - Iran	2
JM - Giamaica	2
LK - Sri Lanka	2
MY - Malesia	2
RO - Romania	2
RS - Serbia	2
TN - Tunisia	2
BA - Bosnia-Erzegovina	1
DK - Danimarca	1
HN - Honduras	1
LB - Libano	1
LU - Lussemburgo	1
ME - Montenegro	1
MN - Mongolia	1
NO - Norvegia	1
NP - Nepal	1
NR - Nauru	1
PS - Palestinian Territory	1
PY - Paraguay	1
SN - Senegal	1
TH - Thailandia	1
TW - Taiwan	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	12.910

Salva come PNG Salva come JPEG

Città	#
Milan	1.059
Fairfield	816
Ashburn	581
San Jose	478
Singapore	463
Chandler	439
Woodbridge	414
Houston	343
Seattle	327
Jacksonville	319
Wilmington	319
Cambridge	260
Hong Kong	255
Ann Arbor	210
Dallas	203
Dearborn	180
Nyköping	178
Princeton	156
Beijing	154
Dublin	141
Como	109
Boardman	101
New York	91
Dong Ket	85
The Dalles	82
Rome	81
Ho Chi Minh City	77
Lauterbourg	75
Chicago	67
Izmir	59
San Diego	59
Los Angeles	51
Munich	50
Kocaeli	44
Hanoi	40
Mexico City	37
Redmond	37
Orem	36
Santa Clara	34
Frankfurt am Main	33
London	33
Ogden	31
São Paulo	27
Helsinki	26
San Mateo	25
Chennai	22
Tokyo	20
Brussels	16
Manchester	16
Warsaw	16
Brooklyn	15
Guangzhou	15
Kunming	14
Nuremberg	14
Johannesburg	13
Toronto	13
Council Bluffs	12
Hefei	12
Phoenix	12
Redwood City	12
Stockholm	12
Amsterdam	11
Denver	11
Haiphong	11
Nanjing	11
Norwalk	11
Washington	11
Abuja	10
Atlanta	10
Boston	10
Buffalo	10
Genoa	10
Montreal	10
Mumbai	10
Turku	10
Belo Horizonte	9
Bologna	9
Falkenstein	9
Rio de Janeiro	9
San Francisco	9
Varese	9
Da Nang	8
Shanghai	8
Vienna	8
Cavaria con Premezzo	7
Hangzhou	7
New Delhi	7
Verona	7
Ankara	6
Berlin	6
Dhaka	6
Guayaquil	6
Nanchang	6
Pune	6
Baghdad	5
Brasília	5
Caxias do Sul	5
Chiswick	5
Cincinnati	5
Elk Grove Village	5
Totale	9.237

Salva come PNG Salva come JPEG

Nome	#
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both	351
Final Results of Northern Italy Leukemia Group (NILG) Trial 10/07 Combining Pediatric-Type Therapy with Minimal Residual Disease Study and Risk-Oriented Hematopoietic Cell Transplantation in Adult Acute Lymphoblastic Leukemia (ALL)	270
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment	256
Vitamin D Deficiency has a Negative Impact on Cetuximab-Mediated Cellular Cytotoxicity against Human Colon Carcinoma Cells	239
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis	234
Right ventricular remodelling in mild hypertensive patients: role of left ventricular morpho-functional parameters	220
Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis	213
ESC position paper on cardiovascular toxicity of cancer treatments: challenges and expectations—comment	207
A particular case of AML patient with the polymorphism G105G (rs11554137) and the missense mutation R132C in IDH1 gene	206
Acute myeloid leukemia with associated translocation t(15;17) and 11q23/MLL abnormality	202
JAK2, 46/1 haplotype and chronic myelogenous leukemia: diagnostic and therapeutic potential	201
sRAGE and early signs of cardiac target organ damage in mild hypertensives	196
Primary extranodal diffuse large B-cell lymphomas: Many sites, many entities? Clinico-pathological, immunohistochemical and cytogenetic study of 106 cases	194
In vitro effects of Apixaban on 5 different cancer cell lines	191
Clinical Impact of an Accurate Genetic Characterization of Older Acute Myeloid Leukemia Patients: A Report from the Northern Italy Leukemia Group (NILG) Randomized Trial 02/06	191
Fatal Splenic Rupture in a Previously Undiagnosed Multiple Myeloma: Morphological, Immunophenotypical and Molecular Cytogenetic Analyses	189
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register	188
Bone marrow necrosis related to imatinib mesylate therapy for cml bilineal blast crisis	188
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.	187
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML	186
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia	184
Assessing residual disease in imatinib-treated CML patients by DNA compared to MRNA assays	183
JAK2 mutation and atypical chronic myeloid leukemia	183
JAK2-V617F mutation and Philadelphia positive chronic myeloid leukemia.	183
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub	183
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients	180
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia	180
Imatinib (IM) discontinuation in chronic myeloid leukemia (CML): A pharmacogenetic score for patients with durable complete molecular response (CMR)	177
A randomized comparison of caspofungin versus antifungal prophylaxis according to investigator policy in acute leukaemia patients undergoing induction chemotherapy (PROFIL-C study).	176
Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia	175
Tirosine kinase inhibitors adverse events	175
Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia	175
Microhomologies and interspersed repeat elements at genomic breakpoints in chronic myeloid leukemia	160
Baseline PET as prognostic index in diffuse large B-cell lymphoma and grade IIIb follicular lymphoma: a retrospective study of a single-centre experience	154
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people	152
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register	152
Megakaryocytic blast crisis as first presentation of chronic myeloid leukemia	150
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards	149
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study	146
Metabolic tumour volume and response to therapy in diffuse large B cell lymphoma	146
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry	146
What changed in the Italian internal medicine and geriatric wards during the lockdown	145
Molecular monitoring of residual disease in chronic myeloid leukemia by genomic DNA compared with conventional mRNA analysis.	142
Caspofungin Primary Antifungal Prophylaxis in Acute Leukemia Patients During Induction Therapy: Results of a Prospective Phase II Multicentric Study (ProfilC Study)	141
Negative impact of high body mass index on cetuximab-mediated cellular cytotoxicity against human colon carcinoma cells	134
Prevention of anthracycline-induced cardiotoxicity: a systematic review and meta-analysis	134
Clinical features, treatment and outcome of patients with low-grade gastric MALT lymphoma: a single centre experience	134
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients	132
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients	131
Current management of cancer-associated venous thromboembolism in patients with thrombocytopenia: a retrospective cohort study	131
Pain and Frailty in Hospitalized Older Adults	129
Identification of a Chromatin-Splicing Mutational Signature to Define Secondary Acute Myeloid Leukemia: A Report from the Northern Italy Leukemia Group (NILG) Prospective Trial 02/06	125
Comment on low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study	125
IN ADULT ACUTE MYELOID LEUKAEMIA (AML) ALL RISK SUBSETS BENEFIT FROM A SEQUENTIAL HIGH-DOSE PROGRAMME AS EARLY RESCUE OF FIRST INDUCTION FAILURE: A REPORT FROM NORTHERN ITALY LEUKAEMIA GROUP (NILG)	124
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry	123
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06	122
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia	121
Antibiotic use and associated factors in a large sample of hospitalised older people	120
Composite follicular lymphoma and “early” (in situ and mantle zone growth pattern) mantle cell neoplasia: A rare entity with peculiar cytogenetic and clinical features	119
Primary non-Hodgkin's lymphoma of the kidney: A case report	119
Tyrosin-Kinase Inhibitors Discontinuation in Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis	118
CEOP 1-8 regimen for treatment of intermediate-high grade non-Hodgkin's lymphoma in elderly patients	115
The multifaceted spectrum of liver cirrhosis in older hospitalised patients: analysis of the REPOSI registry	115
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients	113
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)	113
Primary testicular non-Hodgkin lymphomas. A clinicopathologic study of nine cases	110
Subacute demyelinating polyneuropathy associated with B-cell lymphoma and IgM antibodies against myelin-associated glycoprotein responsive to rituximab	108
NEXT GENERATION SEQUENCING (NGS) CONFIRMED THE ADVERSE CLINICAL IMPACT OF RUNX1 MUTATIONS IN A SUBSET OF ACUTE MYELOID LEUKEMIA NORMAL KARYOTYPE PATIENTS NEGATIVE FOR RISK DEFINING GENES MUTATIONS AND HOMOGENOUSLY TREATED WITHIN A CLINICAL TRIAL (NILG AML 02/06)	106
MOLECULAR PROLIFE BY NEXT GENERATION SEQUENCING OF ACUTE MYELOID LEUKEMIA WITH NORMAL KARYOTYPE: CLINICAL RESULTS FROM THE PROSPECTIVE TRIAL 02/06 OF THE NORTHERN ITALY LEUKEMIA GROUP (NILG)	105
TWO-STEP RESPONSE-ORIENTED INDUCTION PREDICTS LONG-TERM OUTCOME OF ADULT PATIENTS WITH STANDARD- AND HIGH-RISK ACUTE MYELOID LEUKAEMIA (AML): A NORTHERN ITALY LEUKAEMIA GROUP (NILG) STUDY	105
Evaluation of international prognostic factors project for patients with advanced Hodgkin's disease: A single centre experience	104
Association of ARA-C, mitoxantrone and etoposide in elderly affected by acute myeloid leucemia	100
CLINICAL SIGNIFICANCE OF END OF INDUCTION MINIMAL RESIDUAL DISEASE IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN COMPLETE REMISSION AFTER A SINGLE CHEMOTHERAPY COURSE	100
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register)	99
PROGNOSTIC VALUE OF CLONAL HEMATOPOIESIS-MUTATIONS DETECTED AT DIAGNOSIS IN ACUTE MYELOID LEUKEMIA PATIENTS WITH NORMAL KARYOTYPE	92
Primary gastric lymphomas. Clinico-pathological study and evaluation of prognostic factors in 65 cases treated surgically	91
Post-Treatment Residual Disease Detection by Droplet Digital PCR in Hairy Cell Leukemia: Comparison with Allele Specific PCR and Immunohistochemistry	86
Integrated Genomic, Functional and Prognostic Characterization of Atypical Chronic Myeloid Leukemia (aCML) in a Cohort of 43 Patients	84
Association of hairy cell leucemia (HCL) with low-grade non Hodgkin lymphoma (NHL) successfully treated with retuximab. A case report	83
Low efficacy of thalidomide in improving response after induction in myeloma patients candidate to high-dose therapy	78
Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register	75
Body mass index (BMI) influence on Cetuximab-induced antibody-dependent cellular cytotoxicity in advanced colon cancer	75
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register	74
High frequency of BCL2 gene rearrangement-negative follicular lymphoma in northwestern Italy	73
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study	71
BCL2 in follicular lymphomas (FL): the overrated guy?	69
Integrated genomic, functional, and prognostic characterization of atypical chronic myeloid leukemia	67
Multicentric castleman disease with splenic presentation: report of two rare cases with focus on histopathological features and review of the literature	63
Correction to: Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta‑analysis (Internal and Emergency Medicine, (2023), 18, 2, (535-547), 10.1007/s11739-023-03208-9)	61
A case of multicentric Castleman's disease mimicking non-Hodgkin lymphoma: when splenectomy is diagnostic and therapeutic	61
Direct oral anticoagulants in patients with a left-sided bioprosthetic heart valve: a systematic review and meta-analysis	57
Unnecessary use of proton pump inhibitors in patients discharged on oral anticoagulant therapy: data from the REPOSI registry	12
Impact of vitamin D plasma levels on in vitro natural killer cell cytotoxicity against non-small cell lung carcinoma in the presence of nivolumab	7
Idiopathic splanchnic vein thrombosis unmasking a clonal autoinflammatory disease	6
Prescription of ACE-Is/ARBs in patients with cardio-renal disease: a multicenter retrospective cohort study from the REPOSI registry	6
Totale	13.071

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	54.924
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	54.924

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	604	0	0	0	0	0	0	0	0	0	233	167	204
2021/2022	915	134	98	40	55	35	106	33	30	53	171	64	96
2022/2023	1.253	130	86	90	128	101	234	1	189	186	37	36	35
2023/2024	1.724	263	260	244	319	303	159	16	27	62	30	17	24
2024/2025	1.369	25	25	252	40	55	75	63	95	148	122	122	347
2025/2026	3.262	294	250	236	504	337	234	644	199	382	182	0	0
Totale													13.071